Advancing innovation to improve lives
Therapeutic areasFind out more
ProductsFind out more
Learn how we've been delivering on our mission for patients for 90 years.
ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY
In 2022, the company has grown 15% in net revenues and has expanded its presence in Portugal and Italy.
To enable further growth and international expansion, ESTE...
ESTEVE AND MEDTRONIC ARE COLLABORATING TO ADDRESS CANCER PAIN PATIENTS’ NEEDS
ESTEVE and MEDTRONIC have started an initiative to improve the pathway of patients with refractory cancer pain across Europe. Although most cancer sufferers respond well to co...
ESTEVE REINFORCES ITS COMMITMENT TO SUSTAINABILITY IN ALL THREE DIMENSIONS: SOCIAL, ENVIRONMENTAL AND ECONOMIC
2021 has been a key year for the consolidation of its new business model: to become an international, proprietary and specialized pharmaceutical company.
Some of ...